secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seer, Inc. (SEER)
CIK:        0001726445
Form:       8-K
Filed at:   2021-11-08T23:59:59+00:00
Accession:  0001628280-21-022257
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Seer appoints Rachel Haurwitz, Ph.D. to its board; David Singer resigns
-----------------------------------------------------------------------

- Dr. Haurwitz, CEO of Caribou Biosciences, appointed to Seer board effective Nov. 8, 2021 as Class II director.
- David Singer resigned as director effective Nov. 8; no dispute or disagreement with Seer.
- Dr. Haurwitz receives standard non-employee director cash compensation of $40k/year plus initial option for 30,000 shares.
- Deep Nishar replaces Singer on Audit Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726445/000162828021022257/0001628280-21-022257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726445/000162828021022257/seer-20211104.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-022257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer